This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Managed Health Care Associates, Inc. (MHA) Released Results Of Sixth Annual Independent Long Term Care Member Study With Expanded Specialty Pharmacy Findings

FLORHAM PARK, N.J., April 8, 2013 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA), a leading health care service company focused on the alternate site health care provider marketplace, announced the completion of its sixth annual Independent Long Term Care Member Study, the results of which were released at the 2013 MHA Business Summit, February 28, 2013 in Las Vegas, Nevada.

This study was first introduced in 2008 to provide MHA members and other industry stakeholders with additional insight into the operations of independent long term care pharmacies nationwide.  The 2013 report findings include data from over 1,000 nationwide participants, 140M prescriptions and 2.7 M patient profiles across a multitude of residential settings.

Michelle Templin, MHA Vice President Strategic Business Development commented, "In this year's edition, we not only continued to report on the growing utilization of specialty pharmaceuticals within LTC pharmacy but we also analyzed the impact of limited distribution on this population. Additionally, we expanded the study reporting to include financial metrics highlighting average revenue per prescription, generic utilization rates and average revenue per resident. We remain committed to this market and to presenting a useful annual report for members."

Lou Livolsi, MHA Senior Vice President, LTC added, "The Independent Long Term Care Member Study is one of the many MHA proprietary offerings we bring to our LTC membership.  Our members trust that we have their interest in mind in what we do and The LTC Study is a clear example of how we continue to deliver value to member pharmacies."

MHA members who attended the Business Summit were given a complimentary copy of the Independent Long Term Care Member Study.  Members not in attendance were given a copy of the study directly through their Account Management team. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs